Publicacións en colaboración con investigadores/as de University of Toronto (13)

2025

  1. Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)

    World Allergy Organization Journal, Vol. 18, Núm. 7

  2. Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 13, Núm. 8, pp. 2033-2048

  3. Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics

    American Journal of Respiratory and Critical Care Medicine, Vol. 211, Núm. 7, pp. 1165-1174

  4. Response to Biologics Along a Gradient of T2 Involvement in Patients With Severe Asthma: A Data-Driven Biomarker Clustering Approach

    Journal of Allergy and Clinical Immunology: In Practice

2024

  1. Real-world biologics response and super-response in the International Severe Asthma Registry cohort

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 10, pp. 2700-2716

2021

  1. EAACI Biologicals Guidelines—Recommendations for severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44

2020

  1. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057

  2. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042

  3. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068

2019

  1. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine

    American Journal of Cardiovascular Drugs, Vol. 19, Núm. 2, pp. 173-183

  2. Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

    Anesthesiology, Vol. 130, Núm. 2, pp. 263-283

2017

  1. Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

    American Journal of Respiratory and Critical Care Medicine, Vol. 195, Núm. 1, pp. 67-77

2006

  1. Pulmonary Embolism in Patients with Chronic Obstructive Pulmonary Disease or Congestive Heart Failure

    American Journal of Medicine, Vol. 119, Núm. 10, pp. 851-858